Columbus, OH – From Mark Cuban’s latest investments, to a pocket-sized emergency room, the latest and greatest in technology.

Stat Doctors

Have you ever been sitting in the waiting room of a doctor’s office or an urgent care and thought, there needs to be a more efficient way of doing this? Sitting next to “Joe appendicitis” and “Sally sinus infection” is never the ideal experience when you are already feeling unwell.

Stat Doctors is a mobile app that acts as an alternative to visiting your local ER or urgent care. Stat Doctors connects you to ER trained physicians who can help quickly diagnose and treat minor illnesses. With an average wait time of just six minutes, Stat Doctors empowers and encourages patients to act on their non-emergency conditions.

What differentiates this app from similar ones is that the entire healthcare experience is delivered through the app. High-quality video and ePrescriptions allow for a streamlined doctor’s office visit, without the office.


Gmate Smart Glucometer

A Korean medical device company has received regulatory clearance from the FDA to offer its Gmate Smart glucometer in The United States. The Gmate Smart glucometer is a simple glucose monitoring device for even the most novice of smartphone users.

For diabetes patients, using the Gmate Smart glucometer is as simple as plugging the device into the audio jack of your iOS device, inserting a strip, and providing a blood sample. The mobile app allows users to review a log of past readings and see the trends in their recent glucose readings in order to let them know when to maintain or change behaviors as necessary.



Mark Cuban seems to find his way into just about every emerging trend. It comes as no surprise that he has found his way into mobile health monitoring. Cuban has backed the new device called Biomeme. Biomeme is the inexpensive and portable answer for a real-time PCR machine that would typically cost thousands of dollars.

With Biomeme, patients will be able to use their smartphone to perform diagnostic tests on the go, providing doctors with the data they will need to remotely diagnose potential diseases. Beyond patient diagnostics, Biomeme has been proposed for use in forensics testing and even for use by The Department of Defense. If Biomeme overcomes the hurdles of getting into consumers hands I think it could prove to be an instrumental player in mobile health.


Posted by: Zach Gerber

About the Author:

As Managing Director of Innovation and Insights for Syneos Health Communications, Leigh is responsible for building and scaling a global team of healthcare experts who together help life science leaders better understand the complex lives, influences and expectations of their customers. Specifically, they uncover actionable insights that fuel empathy and creativity; lead co-creation events that let marketers learn from peers, trends, and new possibilities; and help clients identify the most valuable and useful new customer experiences to create.

Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly 20 years.She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she held several leadership roles at our largest agency, GSW.  There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business.

Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes.

A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. This year, she led over 250 experts to experts to focus on the most important changes in the commercial, consumer, marketing, digital and healthcare landscapes. (See reports at

Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice and Top 10 Innovation Catalysts of 2017 by MM&M, Leigh also was recognized  as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.